IF 11.5Other软组织/骨肿瘤2026-03
Safety and Efficacy of Epirubicin, Ifosfamide, and Nivolumab as First-line treatment for patients with Undifferentiated Pleomorphic Sarcoma
Martin-Broto J, Martinez-Trufero J, Diaz-Beveridge R, Gutierrez A, Carrasco I, Lopez-Jimenez C, et al. · Clin Cancer Res
结论表柔比星、异环磷酰胺联合纳武利尤单抗治疗晚期UPS安全可行,且显示出较高的抗肿瘤活性。
PMID: 41817407DOI ↗